Thomas Stefan Worst

2.2k total citations
67 papers, 1.1k citations indexed

About

Thomas Stefan Worst is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thomas Stefan Worst has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 32 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Thomas Stefan Worst's work include Bladder and Urothelial Cancer Treatments (29 papers), Urinary and Genital Oncology Studies (15 papers) and Prostate Cancer Treatment and Research (13 papers). Thomas Stefan Worst is often cited by papers focused on Bladder and Urothelial Cancer Treatments (29 papers), Urinary and Genital Oncology Studies (15 papers) and Prostate Cancer Treatment and Research (13 papers). Thomas Stefan Worst collaborates with scholars based in Germany, United Kingdom and Switzerland. Thomas Stefan Worst's co-authors include Philipp Erben, Maurice Stephan Michel, Michael Boutros, Jost von Hardenberg, Julia Christina Gross, Matthias Schulz, Claudia R. Binder, Gry H. Dihazi, Gerrit Erdmann and Kerstin Menck and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Thomas Stefan Worst

60 papers receiving 1.1k citations

Peers

Countries citing papers authored by Thomas Stefan Worst

Since Specialization

Citations

This map shows the geographic impact of Thomas Stefan Worst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stefan Worst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stefan Worst more than expected).

Fields of papers citing papers by Thomas Stefan Worst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Stefan Worst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stefan Worst. The network helps show where Thomas Stefan Worst may publish in the future.

Co-authorship network of co-authors of Thomas Stefan Worst

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Stefan Worst. A scholar is included among the top collaborators of Thomas Stefan Worst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Stefan Worst. Thomas Stefan Worst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use? 2025 ·World Journal of Urology ·Margarete Teresa Walach, (unknown), (unknown), Katja Nitschke, Frederik Wessels, Philipp Nuhn, Thomas Stefan Worst, Jost von Hardenberg, (unknown), (unknown)	0
2	Optimization of extracellular vesicles preparation from saliva of head and neck cancer patients 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), Karen Bieback, Stefanie Uhlig, Marie‐Nicole Theodoraki, Katja Nitschke, Thomas Stefan Worst, (unknown), Claudia Scherl, Nicole Rotter, Sonja Ludwig	6
3	Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy – a propensity-score matched analysis 2024 ·World Journal of Urology ·(unknown), (unknown), (unknown), (unknown), Carl-Erik Dempfle, (unknown), Frederik Wessels, (unknown), Thomas Stefan Worst, Niklas Westhoff, Maximilian C. Kriegmair, Patrick Honeck, Maurice Stephan Michel, Karl‐Friedrich Kowalewski	1
4	Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis 2024 ·Discover Oncology ·(unknown), (unknown), (unknown), Martin Schneider, Dominic Helm, (unknown), Philipp Nuhn, Katja Nitschke, Thomas Stefan Worst	1
5	Relevance of Positive Surgical Margins in Localized Renal Cell Carcinoma After Surgical Resection: Predictive Factors and Survival Implications 2024 ·Clinical Genitourinary Cancer ·(unknown), (unknown), (unknown), Caelán Max Haney, Margarete Teresa Walach, (unknown), Thomas Stefan Worst, Maurice Stephan Michel, Karl‐Friedrich Kowalewski	0
6	Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial 2023 ·European Urology Oncology ·Manuel Neuberger, Karl‐Friedrich Kowalewski, Simon Valentin, Jost von Hardenberg, Fabian Siegel, Frederik Wessels, Thomas Stefan Worst, Maurice Stephan Michel, Niklas Westhoff, Maximilian C. Kriegmair, Patrick Honeck, Philipp Nuhn	8
7	Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia 2021 ·Journal of Clinical Medicine ·Clemens M. Rosenbaum, Malte W. Vetterlein, (unknown), Philipp Reiss, Thomas Stefan Worst, Jennifer Kranz, J. Steffens, Luis A. Kluth, Daniel Pfalzgraf	13
8	RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy 2021 ·International Journal of Molecular Sciences ·(unknown), Helena Schmidt, Katja Nitschke, Cleo‐Aron Weis, Philipp Nuhn, Jost von Hardenberg, Maurice Stephan Michel, Philipp Erben, Thomas Stefan Worst	5
9	Holmium Versus Thulium Laser Enucleation of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials 2021 ·European Urology Focus ·(unknown), Karl‐Friedrich Kowalewski, Jost von Hardenberg, Thomas Stefan Worst, Maximilian C. Kriegmair, Philipp Nuhn, Thomas Herrmann, Maurice Stephan Michel, (unknown)	37
10	Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer 2020 ·International Journal of Molecular Sciences ·(unknown), Katja Nitschke, (unknown), Jost von Hardenberg, Philipp Nuhn, (unknown), Cleo‐Aron Weis, Maurice Stephan Michel, Philipp Erben, Thomas Stefan Worst	6
11	Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer 2020 ·World Journal of Urology ·Niklas Westhoff, (unknown), Karl‐Friedrich Kowalewski, Laura Schmidt, Thomas Stefan Worst, Maurice Stephan Michel, Jost von Hardenberg	17
12	Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer 2020 ·Scientific Reports ·Sébastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, Maximilian C. Kriegmair, Arndt Hartmann, Štefan Porubský, Christian Bolenz, Philipp Erben	2
13	The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery 2020 ·World Journal of Urology ·Karl‐Friedrich Kowalewski, Dennis Müller, (unknown), Jonathan D. Hendrie, Thomas Stefan Worst, Frederik Wessels, Margarete Teresa Walach, Jost von Hardenberg, Philipp Nuhn, Patrick Honeck, Maurice Stephan Michel, Maximilian C. Kriegmair	37
14	Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5 2019 ·World Journal of Urology ·Katja Nitschke, Philipp Erben, (unknown), (unknown), Cleo‐Aron Weis, (unknown), (unknown), Philipp Nuhn, Michael Boutros, Maurice Stephan Michel, Jost von Hardenberg, Thomas Stefan Worst	15
15	miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers 2019 ·Cancers ·Thomas Stefan Worst, Christopher Previti, Katja Nitschke, Nicolle Diessl, Julia Christina Gross, Lena Hoffmann, (unknown), (unknown), Christoph Kahlert, Karen Bieback, Adriana Torres Crigna, Fabia Fricke, Štefan Porubský, Niklas Westhoff, Jost von Hardenberg, Philipp Nuhn, Philipp Erben, Maurice Stephan Michel, Michael Boutros	58
16	ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data 2019 ·Cancers ·Sheng Wu, Katja Nitschke, (unknown), Cleo‐Aron Weis, Thomas Stefan Worst, Markus Eckstein, Štefan Porubský, Philipp Erben	17
17	Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation 2018 ·Clinical Genitourinary Cancer ·Jost von Hardenberg, Sarah Hartmann, Katja Nitschke, Thomas Stefan Worst, Saskia Ting, Henning Reis, Philipp Nuhn, Cleo‐Aron Weis, Philipp Erben	8
18	Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane 2017 ·Journal of Extracellular Vesicles ·Kerstin Menck, (unknown), Thomas Stefan Worst, Matthias Schulz, Gry H. Dihazi, Frank Streit, Gerrit Erdmann, Simon Kling, Michael Boutros, Claudia R. Binder, Julia Christina Gross	256
19	[Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics]. 2017 ·PubMed ·Sebastian Hofbauer, Charis Kalogirou, Florian Roghmann, Anna Katharina Seitz, Stefan Vallo, Felix Wezel, Thomas Stefan Worst, Roman Nawroth	0
20	Beiträge des Kongresses der Deutschen Gesellschaft für Urologie 2013 ·Der Urologe ·Jost von Hardenberg, Thomas Stefan Worst, Christel Weiß, Maurice Stephan Michel	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact